CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 77 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02374775
NCT02374775N/AUnknown
CompareCT.gov

Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamics (EMERALD)

Seoul National University Hospital·observational·Posted Mar 2, 2015·Updated Apr 4, 2017

In Brief

An observational study for Acute Coronary Syndrome and 3 related conditions. Targeting 77 participants across 2 sites.

Detailed Summary

The EMERALD trial is a multinational, multicenter study. The patients presented with AMI/definite evidence of plaque rupture and had underwent coronary CT angiography from 1 month to 2 year prior to the event will be retrospectively searched. Plaques in the non-culprit vessels will be regarded as internal control to the ruptured plaque in the culprit vessel.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Coronary Syndrome, Myocardial Infarction, Plaque, Atherosclerotic, Rupture, Spontaneous
CountriesSouth Korea
CollaboratorsHeartFlow, Inc., Kyoto University, Graduate School of Medicine, Inje University, Keimyung University Dongsan Medical Center, Ulsan University Hospital, Wakayama Medical University, Aarhus University Hospital

Timeline

N/AUnknownOverdue
201520162017201820192020202120222023202420252026
First PostedMar 2, 2015
Enrollment StartSep 1, 2014
Primary CompletionSep 1, 2017
Study CompletionDec 1, 2017
TodayJul 1, 2026
Enrollment to primary: 3 yearsPosted 11.3 years ago